v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities    
Net loss from continuing operations $ (5,354) $ 3,966
Less: income (loss) from discontinued operations, net of tax 8,644
Loss from continuing operations after income taxes (5,354) (4,678)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation and amortization 962 1,482
Amortization of debt discount 476 372
Amortization on operating lease right-of-use assets 121
Loss from investment in unconsolidated affiliates 225
Loss on issuance of debt 12
Loss (gain) from disposal of fixed assets (6) 45
Stock-based compensation expense 390 521
Change in fair value of derivative liability 86
Debt extinguishment loss 278 431
Changes in operating assets and liabilities:    
Accounts receivable (7) (146)
Inventory (2)
Prepaid expenses and other current assets (104) (636)
Accounts payable and accrued expenses 1,180 (391)
Accrued diagnostic services 12
Deferred revenue 484 (143)
Lease liabilities 39 9
Income tax payable 512 (523)
Other liabilities 79 (452)
Net cash used in operating activities - continuing operations (748) (3,978)
Net cash provided by operating activities - discontinued operations 597
Net cash used in operating activities (748) (3,381)
Cash flows from investing activities    
Proceeds from sale of fixed assets 12 53
Capital expenditures
Net cash provided by investing activities - continuing operations 12 53
Net cash provided by investing activities - discontinued operations 800
Net cash provided by investing activities 12 853
Cash flows from financing activities    
Proceeds from issuance of common shares, net 41 3,278
Proceeds from issuance of note payable, net 288 204
Proceeds from issuance of convertible notes payable 392
Repayment of note payable (44) (1,509)
Net cash provided by financing activities - continuing operations 677 1,973
Net cash used in financing activities - discontinued operations (35)
Net cash provided by financing activities 677 1,938
Decrease in cash and cash equivalents (59) (590)
Cash and cash equivalents at the beginning of the period 90 678
Cash and cash equivalents at the end of the period 31 88
Supplemental disclosures:    
Cash paid for income taxes 256
Interest payments 30 376
Supplemental disclosure of non-cash investing and financing activities:    
Issuance of common stock as commitment fee for future financing 158
Issuance of common stock to convert outstanding debt $ 769